Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exercise | 8 | 2020 | 657 | 1.380 |
Why?
|
Health Promotion | 4 | 2017 | 407 | 1.250 |
Why?
|
Diet | 2 | 2021 | 513 | 1.040 |
Why?
|
Cardiorespiratory Fitness | 1 | 2023 | 8 | 0.900 |
Why?
|
Glycation End Products, Advanced | 2 | 2021 | 125 | 0.900 |
Why?
|
Motivation | 2 | 2016 | 561 | 0.820 |
Why?
|
Meditation | 2 | 2012 | 33 | 0.790 |
Why?
|
Genetic Carrier Screening | 1 | 2017 | 25 | 0.610 |
Why?
|
Prenatal Diagnosis | 1 | 2017 | 73 | 0.590 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 3 | 2013 | 87 | 0.580 |
Why?
|
Cell Phone | 3 | 2016 | 43 | 0.570 |
Why?
|
Occupational Health | 1 | 2016 | 41 | 0.550 |
Why?
|
Prehypertension | 2 | 2014 | 39 | 0.540 |
Why?
|
Weight Reduction Programs | 1 | 2016 | 67 | 0.520 |
Why?
|
Health Education | 1 | 2016 | 279 | 0.470 |
Why?
|
Blood Pressure | 3 | 2014 | 1447 | 0.440 |
Why?
|
Surveys and Questionnaires | 4 | 2017 | 2798 | 0.440 |
Why?
|
Circadian Rhythm | 1 | 2013 | 218 | 0.430 |
Why?
|
Weight Loss | 1 | 2015 | 319 | 0.420 |
Why?
|
Endothelin-1 | 1 | 2013 | 122 | 0.420 |
Why?
|
Psychometrics | 1 | 2015 | 514 | 0.420 |
Why?
|
Monitoring, Ambulatory | 1 | 2012 | 84 | 0.420 |
Why?
|
Infant, Premature | 3 | 2022 | 284 | 0.400 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 766 | 0.400 |
Why?
|
Respiratory Mechanics | 1 | 2010 | 33 | 0.380 |
Why?
|
Infant, Premature, Diseases | 2 | 2021 | 85 | 0.380 |
Why?
|
Heart Rate | 1 | 2012 | 568 | 0.370 |
Why?
|
Sodium | 1 | 2010 | 161 | 0.370 |
Why?
|
Patient Compliance | 1 | 2012 | 402 | 0.360 |
Why?
|
Humans | 32 | 2023 | 68525 | 0.350 |
Why?
|
Overweight | 2 | 2008 | 186 | 0.350 |
Why?
|
Obesity | 2 | 2015 | 1074 | 0.340 |
Why?
|
Pilot Projects | 3 | 2021 | 1341 | 0.280 |
Why?
|
Female | 20 | 2022 | 38015 | 0.280 |
Why?
|
Stress, Psychological | 1 | 2012 | 824 | 0.270 |
Why?
|
Aggression | 1 | 2005 | 98 | 0.260 |
Why?
|
Life Style | 2 | 2018 | 338 | 0.260 |
Why?
|
Hypertension | 2 | 2013 | 1531 | 0.250 |
Why?
|
Social Behavior | 1 | 2005 | 164 | 0.250 |
Why?
|
Interpersonal Relations | 1 | 2005 | 209 | 0.240 |
Why?
|
Cognition | 1 | 2007 | 512 | 0.230 |
Why?
|
Male | 13 | 2022 | 37281 | 0.230 |
Why?
|
Adult | 10 | 2023 | 21375 | 0.220 |
Why?
|
Heart Failure | 2 | 2022 | 1179 | 0.220 |
Why?
|
Infant, Small for Gestational Age | 1 | 2022 | 44 | 0.210 |
Why?
|
Thyroxine | 1 | 2022 | 62 | 0.210 |
Why?
|
Receptors, Estrogen | 2 | 2020 | 142 | 0.200 |
Why?
|
Awareness | 2 | 2012 | 81 | 0.200 |
Why?
|
Fasting | 1 | 2021 | 75 | 0.200 |
Why?
|
Healthy Lifestyle | 1 | 2021 | 21 | 0.200 |
Why?
|
Surgeons | 1 | 2022 | 68 | 0.200 |
Why?
|
Bone Density | 1 | 2022 | 159 | 0.200 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2022 | 117 | 0.200 |
Why?
|
Cancer Survivors | 2 | 2020 | 145 | 0.190 |
Why?
|
Mothers | 1 | 2022 | 172 | 0.190 |
Why?
|
Acute Coronary Syndrome | 1 | 2022 | 195 | 0.190 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 164 | 0.180 |
Why?
|
Breast Neoplasms | 2 | 2020 | 1533 | 0.180 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2021 | 119 | 0.170 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 221 | 0.170 |
Why?
|
Patient Discharge | 1 | 2021 | 294 | 0.170 |
Why?
|
Heart Transplantation | 1 | 2022 | 328 | 0.170 |
Why?
|
Aromatherapy | 1 | 2018 | 4 | 0.170 |
Why?
|
Qualitative Research | 2 | 2017 | 368 | 0.160 |
Why?
|
Young Adult | 5 | 2018 | 5708 | 0.160 |
Why?
|
Body Mass Index | 2 | 2020 | 866 | 0.160 |
Why?
|
Breast | 1 | 2018 | 137 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2017 | 37 | 0.150 |
Why?
|
Cardiovascular Diseases | 2 | 2017 | 938 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2016 | 26 | 0.150 |
Why?
|
Risk Factors | 5 | 2022 | 5719 | 0.150 |
Why?
|
Preoperative Care | 1 | 2018 | 275 | 0.140 |
Why?
|
Gestational Age | 3 | 2022 | 389 | 0.140 |
Why?
|
Telecommunications | 1 | 2016 | 31 | 0.140 |
Why?
|
Pharmacogenomic Testing | 1 | 2016 | 7 | 0.140 |
Why?
|
Nurse Anesthetists | 1 | 2016 | 10 | 0.140 |
Why?
|
Workplace | 1 | 2016 | 75 | 0.140 |
Why?
|
Dementia | 1 | 2017 | 158 | 0.140 |
Why?
|
Physical Fitness | 1 | 2017 | 117 | 0.140 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 696 | 0.140 |
Why?
|
Middle Aged | 7 | 2022 | 21119 | 0.140 |
Why?
|
Anxiety | 1 | 2018 | 422 | 0.130 |
Why?
|
Adolescent | 4 | 2018 | 8903 | 0.130 |
Why?
|
Coronary Disease | 1 | 2016 | 358 | 0.130 |
Why?
|
Salivary alpha-Amylases | 1 | 2014 | 4 | 0.120 |
Why?
|
Rural Population | 1 | 2017 | 397 | 0.120 |
Why?
|
Caregivers | 1 | 2017 | 365 | 0.120 |
Why?
|
Yoga | 1 | 2014 | 18 | 0.120 |
Why?
|
Internet | 2 | 2016 | 390 | 0.120 |
Why?
|
Transients and Migrants | 1 | 2013 | 22 | 0.110 |
Why?
|
Pain | 1 | 2016 | 472 | 0.110 |
Why?
|
Health Behavior | 1 | 2017 | 458 | 0.110 |
Why?
|
South Carolina | 3 | 2017 | 2750 | 0.110 |
Why?
|
Alzheimer Disease | 1 | 2017 | 563 | 0.110 |
Why?
|
Hydrocortisone | 1 | 2014 | 291 | 0.110 |
Why?
|
Adenosine Diphosphate | 2 | 2022 | 66 | 0.110 |
Why?
|
Alleles | 1 | 2013 | 386 | 0.110 |
Why?
|
Respiration | 1 | 2012 | 91 | 0.110 |
Why?
|
Mass Screening | 1 | 2017 | 837 | 0.100 |
Why?
|
Infant, Newborn | 3 | 2022 | 2453 | 0.100 |
Why?
|
Infant | 3 | 2022 | 2891 | 0.100 |
Why?
|
Gastrostomy | 2 | 2021 | 110 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 627 | 0.090 |
Why?
|
Treatment Outcome | 4 | 2022 | 7028 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2022 | 7264 | 0.090 |
Why?
|
Electrocardiography | 2 | 2022 | 601 | 0.090 |
Why?
|
Reversal Learning | 1 | 2008 | 7 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 929 | 0.080 |
Why?
|
Time Factors | 1 | 2016 | 4655 | 0.080 |
Why?
|
Pattern Recognition, Visual | 1 | 2008 | 69 | 0.080 |
Why?
|
Georgia | 1 | 2007 | 161 | 0.080 |
Why?
|
Snoring | 1 | 2006 | 8 | 0.070 |
Why?
|
Attention | 1 | 2008 | 225 | 0.070 |
Why?
|
Child | 4 | 2014 | 6400 | 0.070 |
Why?
|
Decision Making | 1 | 2008 | 410 | 0.060 |
Why?
|
Telemedicine | 1 | 2013 | 699 | 0.060 |
Why?
|
Nitroprusside | 1 | 2022 | 42 | 0.050 |
Why?
|
Troponin | 1 | 2022 | 25 | 0.050 |
Why?
|
Brain Death | 1 | 2022 | 34 | 0.050 |
Why?
|
Fetal Growth Retardation | 1 | 2022 | 56 | 0.050 |
Why?
|
Methylprednisolone | 1 | 2022 | 99 | 0.050 |
Why?
|
Vasoconstrictor Agents | 1 | 2022 | 107 | 0.050 |
Why?
|
Body Composition | 1 | 2022 | 119 | 0.050 |
Why?
|
Weight Gain | 1 | 2022 | 135 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2022 | 138 | 0.050 |
Why?
|
Vitamins | 1 | 2022 | 134 | 0.050 |
Why?
|
Chest Pain | 1 | 2022 | 151 | 0.050 |
Why?
|
Bundle-Branch Block | 1 | 2021 | 50 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2022 | 221 | 0.050 |
Why?
|
Lactation | 1 | 2022 | 110 | 0.050 |
Why?
|
Plant Extracts | 1 | 2022 | 122 | 0.050 |
Why?
|
Perception | 1 | 2022 | 189 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 113 | 0.050 |
Why?
|
Tissue Donors | 1 | 2022 | 195 | 0.050 |
Why?
|
Breast Feeding | 1 | 2022 | 159 | 0.050 |
Why?
|
Stroke Volume | 1 | 2022 | 586 | 0.040 |
Why?
|
Aged | 3 | 2021 | 14842 | 0.040 |
Why?
|
Graft Survival | 1 | 2022 | 465 | 0.040 |
Why?
|
Hemodynamics | 1 | 2022 | 705 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2022 | 331 | 0.040 |
Why?
|
Lavandula | 1 | 2018 | 4 | 0.040 |
Why?
|
Neoplasm Grading | 1 | 2018 | 110 | 0.040 |
Why?
|
Tamoxifen | 1 | 2018 | 62 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 99 | 0.040 |
Why?
|
United States | 1 | 2010 | 7335 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2022 | 1737 | 0.040 |
Why?
|
Vitamin D | 1 | 2022 | 516 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2021 | 738 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 332 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2018 | 799 | 0.030 |
Why?
|
Text Messaging | 1 | 2016 | 47 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 951 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 711 | 0.030 |
Why?
|
Pregnancy | 1 | 2021 | 2331 | 0.030 |
Why?
|
Self Report | 1 | 2017 | 370 | 0.030 |
Why?
|
Telephone | 1 | 2016 | 160 | 0.030 |
Why?
|
Risk Assessment | 1 | 2022 | 2004 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 2264 | 0.030 |
Why?
|
Anesthesiology | 1 | 2016 | 63 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2016 | 106 | 0.030 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 148 | 0.030 |
Why?
|
Mobile Applications | 1 | 2016 | 138 | 0.030 |
Why?
|
Mental Health | 1 | 2016 | 278 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 1849 | 0.030 |
Why?
|
Agriculture | 1 | 2013 | 54 | 0.030 |
Why?
|
Biomarkers | 1 | 2018 | 1593 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 442 | 0.030 |
Why?
|
Brain | 1 | 2022 | 2175 | 0.030 |
Why?
|
Attitude to Health | 1 | 2013 | 403 | 0.020 |
Why?
|
Signal Transduction | 1 | 2018 | 2688 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2018 | 4843 | 0.020 |
Why?
|
Problem Solving | 1 | 2008 | 36 | 0.020 |
Why?
|
Chronic Disease | 1 | 2013 | 1329 | 0.020 |
Why?
|
Arousal | 1 | 2008 | 168 | 0.020 |
Why?
|
Functional Laterality | 1 | 2008 | 240 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2008 | 213 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 2006 | 40 | 0.020 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 69 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 189 | 0.020 |
Why?
|
Age Factors | 1 | 2008 | 1860 | 0.010 |
Why?
|
Prevalence | 1 | 2006 | 1609 | 0.010 |
Why?
|